Free Radicals and Tardive Dyskinesia

Remington G. Pharmacotherapy of schizophrenia. Can J Psychiatry 1989; 34(3): 211–220.

Cadet J.L. , Lohr J.B. , Jeste D.V. Tardive dyskinesia and schizophrenic burnout: the possible involvement of cytotoxic free radicals. Handbook of schizophrenia, Vol. 2: Neurochemistry and neuropharmacology of schizophrenia. Elsevier Science Publishers B.V., 1987: 425–438.

Cadet J.L. A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem. Med Hypotheses 1988; 27: 59–63.

Grimes J.D. , Hassan M.N. , Thakar J.H. Prevention of progression of Parkinson's disease with antioxidative therapy. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12: 165–172.

Cadet J.L. , Lohr J.B. , Jeste D.V. Free radicals and tardive dyskinesia. Trends in Neuroscience (TINS) 1986; 9: 107–108.

Cohen G. Oxy-radical toxicity in catecholamine neurons. Neurotoxicology 1984; 5(1): 77–82.

Lohr J.B. , Cadet J.L. , Wyatt R.J. Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by alpha-tocopherol (Vitamin E). Neuropsychopharmacology 1988; 1(4): 305–309.

Cadet J.L. , Katz M. , Jackson-Lewis V. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res 1989; 476: 10–15.

Lohr J.B. , Cadet J.L. , Lohr M.A. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull 1988; 14(2): 291–296.